144 related articles for article (PubMed ID: 36513192)
41. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
42. Selecting key genes associated with osteosarcoma based on a differential expression network.
Wang YB; Jia N; Xu CM; Zhao L; Zhao Y; Wang X; Jia TH
Genet Mol Res; 2015 Dec; 14(4):17708-17. PubMed ID: 26782416
[TBL] [Abstract][Full Text] [Related]
43. Identification of potential biological targets of oxindole scaffolds via
Tinivella A; Pinzi L; Gambacorta G; Baxendale I; Rastelli G
F1000Res; 2022; 11():. PubMed ID: 37767081
[No Abstract] [Full Text] [Related]
44. Identification of potential key genes associated with osteosarcoma based on integrated bioinformatics analyses.
Hu G; Cheng Z; Wu Z; Wang H
J Cell Biochem; 2019 Aug; 120(8):13554-13561. PubMed ID: 30920023
[TBL] [Abstract][Full Text] [Related]
45. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
[TBL] [Abstract][Full Text] [Related]
46. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing.
Wu Y; Warner JL; Wang L; Jiang M; Xu J; Chen Q; Nian H; Dai Q; Du X; Yang P; Denny JC; Liu H; Xu H
JCO Clin Cancer Inform; 2019 May; 3():1-9. PubMed ID: 31141421
[TBL] [Abstract][Full Text] [Related]
47. PTEN in osteosarcoma: Recent advances and the therapeutic potential.
Zheng C; Tang F; Min L; Hornicek F; Duan Z; Tu C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188405. PubMed ID: 32827577
[TBL] [Abstract][Full Text] [Related]
48. The role of pharmacogenetics in the treatment of osteosarcoma.
Vos HI; Coenen MJ; Guchelaar HJ; Te Loo DM
Drug Discov Today; 2016 Nov; 21(11):1775-1786. PubMed ID: 27352631
[TBL] [Abstract][Full Text] [Related]
49. Identification of characteristic gene modules of osteosarcoma using bioinformatics analysis indicates the possible molecular pathogenesis.
Li H; He Y; Hao P; Liu P
Mol Med Rep; 2017 Apr; 15(4):2113-2119. PubMed ID: 28259906
[TBL] [Abstract][Full Text] [Related]
50. Observation of significant biomarkers in osteosarcoma via integrating module- identification method with attract.
Qi J; Ma L; Wang X; Li Y; Wang K
Cancer Biomark; 2017 Jul; 20(1):87-93. PubMed ID: 28759958
[TBL] [Abstract][Full Text] [Related]
51. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
52. Integrating transcriptomics and network analysis-based multiplexed drug repurposing to screen drug candidates for M2 macrophage-associated castration-resistant prostate cancer bone metastases.
Chang J; Jiang Z; Ma T; Li J; Chen J; Ye P; Feng L
Front Immunol; 2022; 13():989972. PubMed ID: 36389722
[TBL] [Abstract][Full Text] [Related]
53. Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis.
Chen X; Zhang N; Zheng Y; Tong Z; Yang T; Kang X; He Y; Dong L
Comput Math Methods Med; 2022; 2022():7549894. PubMed ID: 35075370
[TBL] [Abstract][Full Text] [Related]
54. Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications.
He H; Duo H; Hao Y; Zhang X; Zhou X; Zeng Y; Li Y; Li B
Comput Biol Med; 2023 Mar; 155():106671. PubMed ID: 36805225
[TBL] [Abstract][Full Text] [Related]
55. CpG methylation patterns are associated with gene expression variation in osteosarcoma.
Wang Q
Mol Med Rep; 2017 Jul; 16(1):901-907. PubMed ID: 28560411
[TBL] [Abstract][Full Text] [Related]
56. Drug repurposing for rheumatoid arthritis: Identification of new drug candidates
Unal U; Comertpay B; Demirtas TY; Gov E
Autoimmunity; 2022 May; 55(3):147-156. PubMed ID: 35048767
[TBL] [Abstract][Full Text] [Related]
57. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
[TBL] [Abstract][Full Text] [Related]
58. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
59. Molecular classification of osteosarcoma.
Lau CC
Cancer Treat Res; 2009; 152():459-65. PubMed ID: 20213408
[TBL] [Abstract][Full Text] [Related]
60. Identification of Pathogenic Genes and Transcription Factors in Osteosarcoma.
Yang C; Huang D; Ma C; Ren J; Fu L; Cheng C; Li B; Shi X
Pathol Oncol Res; 2020 Apr; 26(2):1041-1048. PubMed ID: 30982140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
